Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.3M Sell
50,751
-32
-0.1% -$8.44K 1.99% 21
2026
Q2
$11.2M Buy
50,783
+16,279
+47% +$4.5M 1.68% 26
2026
Q1
$10.2M Sell
34,504
-107
-0.3% -$31.8K 1.74% 25
2025
Q4
$9.45M Sell
34,611
-576
-2% -$157K 1.55% 28
2025
Q3
$9.5M Buy
35,187
+4,780
+16% +$1.3M 1.49% 26
2025
Q2
$8.38M Sell
30,407
-2,009
-6% -$546K 1.43% 28
2025
Q1
$8.6M Sell
32,416
-1,257
-4% -$310K 1.49% 29
2024
Q4
$7.82M Sell
33,673
-895
-3% -$206K 1.4% 33
2024
Q3
$7.63M Buy
34,568
+1,496
+5% +$310K 1.35% 33
2024
Q2
$6.5M Buy
33,072
+19,806
+149% +$4.09M 1.3% 38
2024
Q1
$2.86M Buy
+13,266
New +$2.79M 0.54% 45

Other funds holding CME

Capital Management's CME Position: Q3 2026 in Review

Capital Management reduced its CME Group (CME) stake by 0.06% in Q3 2026, selling an estimated $8.44K and leaving 50,751 shares worth $13.3M. The position accounts for 1.99% of the portfolio, ranked #21.

Capital Management first reported a position in CME in Q1 2024 and has held it in 11 quarters since. 1,007 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Capital Management held 50,751 shares of CME Group worth $13.3M as of Q3 2026.
  • Capital Management sold 32 CME Group shares in Q3 2026, an estimated $8.44K.
  • CME Group made up 1.99% of Capital Management's portfolio in Q3 2026, its #21 holding.
  • Capital Management first reported a position in CME Group in Q1 2024 and has held it in 11 quarters since.
  • 1,007 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.